People affected by schizophrenia often experience poor concentration, lapses in memory and
difficulty with completing tasks; and this set of problems are known as neuro-cognitive
deficits. Traditional medications used in the treatment of schizophrenia have not been
particularly useful in improving these problems, while the recently introduced medications
are expected to be superior in this respect. The proposed research study is designed to
assess the effect of two of the new medications (Zyprexa and Seroquel) in improving the
neurocognitive deficits associated with schizophrenia.